BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1138231)

  • 21. [Osteogenesis imperfecta. Presentation of 5 cases. Nosographical classification and therapeutic prospects].
    Bianchi C; Carcano G
    Minerva Pediatr; 1978 Nov; 30(21):1689-96. PubMed ID: 723815
    [No Abstract]   [Full Text] [Related]  

  • 22. [Osteogenesis imperfecta and calcitonin. Considerations on 10 years of clinical experimentation].
    Baratelli M; Rizzi M; Corradi A
    Arch Sci Med (Torino); 1983; 140(4):379-83. PubMed ID: 6673703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum calcitonin and bone mineral content in patients with osteogenesis imperfecta.
    Nielsen HE; Pedersen U; Hansen HH; Elbrønd O
    Acta Orthop Scand; 1979 Dec; 50(6 Pt 1):639-43. PubMed ID: 532592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An electron microscopic investigation of human familial bone dysplasia. Inhibition of osteocytic osteolysis and induction of osteocytic formation of elastic fibers following calcitonin treatment.
    Nunez EA; Horwith M; Krook L; Whalen JP
    Am J Pathol; 1979 Jan; 94(1):1-18. PubMed ID: 760539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin therapy of children with osteogenesis imperfecta.
    August GP; Shapiro J; Hung W
    J Pediatr; 1977 Dec; 91(6):1001-5. PubMed ID: 562930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteogenesis imperfecta: a histometric analysis.
    Falvo KA; Bullough PG
    J Bone Joint Surg Am; 1973 Mar; 55(2):275-86. PubMed ID: 4696160
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of porcine calcitonin therapy on vitamin D metabolism and clinical response in a patient with osteogenesis imperfecta.
    Nishi Y; Hyodo S; Ishida M; Yamaoka K; Seino Y; Usui T
    Acta Paediatr Scand; 1983 Jan; 72(1):149-52. PubMed ID: 6858681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alkaline phosphatase and its isoenzyme activity of the blood in osteogenesis imperfecta before and during treatment with calcitonin].
    Bodziony J; Lukas W; Stanosek J; Ziarek S
    Padiatr Grenzgeb; 1988; 27(4):259-67. PubMed ID: 3174140
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta.
    Shapiro JR; McCarthy EF; Rossiter K; Ernest K; Gelman R; Fedarko N; Santiago HT; Bober M
    Calcif Tissue Int; 2003 Feb; 72(2):103-12. PubMed ID: 12457260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic bone disease in children.
    Steendijk R
    Clin Orthop Relat Res; 1971; 77():247-75. PubMed ID: 4335242
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta.
    Nishi Y; Hamamoto K; Kajiyama M; Ono H; Kihara M; Jinno K
    J Pediatr; 1992 Sep; 121(3):477-80. PubMed ID: 1517930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Osteogenesis imperfects].
    Santacroce A; Pipino F
    Minerva Pediatr; 1971 Feb; 23(7):287-98. PubMed ID: 4252435
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteogenesis imperfecta clinical features, hearing loss and stapedectomy. Biochemical, osteodensitometric, corneometric and histological aspects in comparison with otosclerosis.
    Pedersen U
    Acta Otolaryngol Suppl; 1985; 415():1-36. PubMed ID: 3859176
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of osteogenesis imperfecta with calcitonin].
    Socha J; Brzozowska-Wolnik D; Ignyś I; Stańska M
    Pediatr Pol; 1982; 57(9):735-7. PubMed ID: 6763191
    [No Abstract]   [Full Text] [Related]  

  • 35. [The histo- and ultrastructural characteristics of the bone tissue in osteogenesis imperfecta].
    Osipenkova TK; Mikhaĭlova LN
    Sud Med Ekspert; 1991; 34(1):18-24. PubMed ID: 1858111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electron microscopic and histochemical investigation of osteogenesis imperfecta tarda.
    Doty SB; Mathews RS
    Clin Orthop Relat Res; 1971 Oct; 80():191-201. PubMed ID: 5133325
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sodium fluoride therapy of osteogenesis imperfecta in childhood].
    Laszlo A; Sugar E
    Kinderarztl Prax; 1982 Aug; 50(8):416-22. PubMed ID: 7143914
    [No Abstract]   [Full Text] [Related]  

  • 38. Bone collagenase in assessment of the clinical course of metabolic bone disease.
    Gardner B; Wallach S; Gray H; Baker RK
    Surg Forum; 1971; 22():435-7. PubMed ID: 4330605
    [No Abstract]   [Full Text] [Related]  

  • 39. [Collagen metabolism in osteogenesis imperfecta].
    Balaba TIa; Furtseva LN; Nefed'eva NN
    Vopr Med Khim; 1974; 20(5):471-6. PubMed ID: 4456796
    [No Abstract]   [Full Text] [Related]  

  • 40. Systemic treatment of osteogenesis imperfecta.
    Albright JA
    Clin Orthop Relat Res; 1981 Sep; (159):88-96. PubMed ID: 7285474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.